Patient Characteristics (n = 75)
| Characteristic | Conventional (n = 44) | Digital (n = 28) | All (n = 72) | P |
|---|---|---|---|---|
| Age (y) | 0.020* | |||
| Median | 42.4 | 57.2 | 51.0 | |
| Range | 19.8–73.7 | 20.3–78.6 | 19.8–78.6 | |
| Female sex | 15 (34) | 14 (50) | 29 (40) | 0.273 |
| Primary histopathologic type | 0.305 | |||
| Astrocytoma, IDH-mutant | 10 (23) | 7 (25) | 17 (24) | |
| Anaplastic astrocytoma, IDH-mutant | 5 (11) | 1 (4) | 6 (8) | |
| Astrocytoma, IDH-wild-type | 2 (5) | 3 (11) | 5 (7) | |
| Anaplastic astrocytoma, IDH-wild-type | 2 (5) | 3 (11) | 5 (7) | |
| Oligodendroglioma, IDH-mutant and 1p/19q codeleted | 7 (16) | 4 (14) | 11 (15) | |
| Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted | 7 (16) | 0 (0) | 7 (10) | |
| Glioblastoma, IDH-wild-type | 10 (23) | 9 (32) | 19 (26) | |
| Glioblastoma, IDH-mutant | 1 (2) | 1 (4) | 2 (3) | |
| Carbidopa premedication | 14 (32) | 28 (100) | 42 (58) | <0.001* |
| Contrast enhancement on MRI | 18 (41) | 11 (39) | 29 (40) | 1 |
↵* P < 0.05 for comparison between conventional PET and digital PET patients.
Data are number followed by percentage in parentheses, except for age.